GEN - Genetic Engineering and Biotechnology News13d
Lilly Plans to More than Double U.S. Manufacturing Investment Since 2020 Exceeding $50 Billion
At the four new sites, Lilly expects to create more than 3,000 jobs for engineers, scientists, operations personnel, and lab ...
Indianapolis Business Journal8d
Zepbound raises profile of Lilly’s direct-to-consumer sales initiative
Indianapolis-based Eli Lilly and Co. launched LillyDirect a little more than a year ago and has been ramping up efforts to ...
Federal judge stops compounded copies of Eli Lilly weight loss, diabetes drugs
A federal judge has effectively ended the ability of compounding pharmacies to make their own copies of Eli Lilly’s weight ...
Zacks Investment Research on MSN2d
Eli Lilly Rises 7.5% YTD: Time to Buy, Sell or Hold the Stock?
Eli Lilly and Company’s LLY shares dipped almost 5% on Monday after rival Novo Nordisk NVO announced disappointing data from ...
Verywell Health on MSN13d
Eli Lilly Lowers Cost of Zepbound Vials to Attract People Without Insurance Coverage
Eli Lilly is now offering four doses of Zepbound in self-administration vials. The lower-cost self-pay option targets people ...
Health.com7d
Zepbound Is Now Available in Additional Doses at Lower Costs
To use the vials, people have to draw out the medicine with a syringe and inject themselves with a needle. Before launching the Zepbound vials in 2024, Eli Lilly offered the drug only in a single ...
PharmExec10d
Eli Lilly Announces Four New Domestic Production Sites
In a press release, Lilly chair and CEO David A. Ricks said, “Lilly's optimism about the potential of our pipeline across ...
Medical Marketing & Media9d
Faced with compounded drugs, Eli Lilly tells consumers to ‘be a healthy skeptic’
Eli Lilly is seeking to further cement its stance as a leader in weight loss drugs in an ad campaign calling out “unapproved” medications.
AOL13d
Eli Lilly Doubles Capital Spending On US Drug Manufacturing With $50 Billion Target (CORRECTED)
At a press conference in Washington, D.C., Eli Lilly And Co (NYSE:LLY) announced its plans to bolster its domestic medicine production across therapeutic areas by building four new pharmaceutical ...